Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161


Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons.

Margolis EB, Hjelmstad GO, Bonci A, Fields HL.

J Neurosci. 2003 Nov 5;23(31):9981-6.


Both kappa and mu opioid agonists inhibit glutamatergic input to ventral tegmental area neurons.

Margolis EB, Hjelmstad GO, Bonci A, Fields HL.

J Neurophysiol. 2005 Jun;93(6):3086-93. Epub 2004 Dec 22.


Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.

Ehrich JM, Messinger DI, Knakal CR, Kuhar JR, Schattauer SS, Bruchas MR, Zweifel LS, Kieffer BL, Phillips PE, Chavkin C.

J Neurosci. 2015 Sep 16;35(37):12917-31. doi: 10.1523/JNEUROSCI.2444-15.2015.


Ethanol dually modulates GABAergic synaptic transmission onto dopaminergic neurons in ventral tegmental area: role of mu-opioid receptors.

Xiao C, Ye JH.

Neuroscience. 2008 Apr 22;153(1):240-8. doi: 10.1016/j.neuroscience.2008.01.040. Epub 2008 Feb 6.


Mu and kappa opioid agonists modulate ventral tegmental area input to the ventral pallidum.

Mitrovic I, Napier TC.

Eur J Neurosci. 2002 Jan;15(2):257-68.


Direct inhibition of hypothalamic proopiomelanocortin neurons by dynorphin A is mediated by the μ-opioid receptor.

Pennock RL, Hentges ST.

J Physiol. 2014 Oct 1;592(19):4247-56. doi: 10.1113/jphysiol.2014.275339. Epub 2014 Aug 1.


Midbrain dopamine neurons: projection target determines action potential duration and dopamine D(2) receptor inhibition.

Margolis EB, Mitchell JM, Ishikawa J, Hjelmstad GO, Fields HL.

J Neurosci. 2008 Sep 3;28(36):8908-13. doi: 10.1523/JNEUROSCI.1526-08.2008.


Implication of dopaminergic projection from the ventral tegmental area to the anterior cingulate cortex in μ-opioid-induced place preference.

Narita M, Matsushima Y, Niikura K, Narita M, Takagi S, Nakahara K, Kurahashi K, Abe M, Saeki M, Asato M, Imai S, Ikeda K, Kuzumaki N, Suzuki T.

Addict Biol. 2010 Oct;15(4):434-47. doi: 10.1111/j.1369-1600.2010.00249.x. Epub 2010 Aug 23.


Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes.

Spanagel R, Almeida OF, Shippenberg TS.

Eur J Pharmacol. 1994 Oct 24;264(2):157-62.


kappa-Opioid tolerance and dependence in cultures of dopaminergic midbrain neurons.

Dalman FC, O'Malley KL.

J Neurosci. 1999 Jul 15;19(14):5750-7.


Analysis of opioid receptor subtype antagonist effects upon mu opioid agonist-induced feeding elicited from the ventral tegmental area of rats.

Lamonte N, Echo JA, Ackerman TF, Christian G, Bodnar RJ.

Brain Res. 2002 Mar 1;929(1):96-100.


Prefrontal cortical kappa-opioid receptor modulation of local neurotransmission and conditioned place aversion.

Tejeda HA, Counotte DS, Oh E, Ramamoorthy S, Schultz-Kuszak KN, Bäckman CM, Chefer V, O'Donnell P, Shippenberg TS.

Neuropsychopharmacology. 2013 Aug;38(9):1770-9. doi: 10.1038/npp.2013.76. Epub 2013 Mar 29.


Mu and kappa opioids modulate mouse embryonic stem cell-derived neural progenitor differentiation via MAP kinases.

Hahn JW, Jagwani S, Kim E, Rendell VR, He J, Ezerskiy LA, Wesselschmidt R, Coscia CJ, Belcheva MM.

J Neurochem. 2010 Mar;112(6):1431-41. doi: 10.1111/j.1471-4159.2009.06479.x. Epub 2009 Nov 6.


Direct bidirectional μ-opioid control of midbrain dopamine neurons.

Margolis EB, Hjelmstad GO, Fujita W, Fields HL.

J Neurosci. 2014 Oct 29;34(44):14707-16. doi: 10.1523/JNEUROSCI.2144-14.2014.


Opioid-sensitive GABA inputs from rostromedial tegmental nucleus synapse onto midbrain dopamine neurons.

Matsui A, Williams JT.

J Neurosci. 2011 Nov 30;31(48):17729-35. doi: 10.1523/JNEUROSCI.4570-11.2011.


Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1.

Vaughan CW, Bagley EE, Drew GM, Schuller A, Pintar JE, Hack SP, Christie MJ.

Br J Pharmacol. 2003 May;139(2):362-7.


Supplemental Content

Support Center